Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 10, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top ten

Friday again, and we bring you the most read articles on our site this week – one of which was …

News
dynavax

Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017
Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …

News
sanofi_new_paris_hq

Sanofi signs $805 million deal for MS drug

November 10, 2017
Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …

News
shutterstock_187433765

Breast cancer recurrence can occur up to 20 years after treatment, report shows

November 10, 2017
Medical Communications, Research and Development Cancer, breast cancer, pharma, tamoxifen

New findings from the Early Breast Cancer Trialists’ Collaborative Group have demonstrated that oestrogen receptor-positive (ER-positive) breast cancer is able …

News
child-2916844_960_720

Sage scores good but not great P3 postpartum depression drug results

November 10, 2017
Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical

Sage Therapeutics share price soared 50% on the release that its two Phase 3 trials of brexanolone showed statistically significant …

News

Recipharm Interim report January – September 2017

November 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Interim report January – September 2017 July – September 2017    

News
Press release

Recipharm to end operations in two facilities in Sweden

November 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …

News
Press release
nhs_sign

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

News
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017
Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …

News
seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News
simon-stevens

NHS Chief in high-stakes gambit to boost funding in autumn budget

November 9, 2017
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

It speaks to the desperation of the funding crisis for the NHS that Chief Executive of the NHS, Simon Stevens, …

News
gsk_wall

GSK indicates a return to oncology by appointing Roche veteran

November 9, 2017
Medical Communications GSK, Hal Barron, biotech, drugs, pharma, pharmaceutical

GSK, under its new CEO, has made most of its waves recently not with approvals but with high-profile appointments, and …

News
shutterstock_206748499

17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows

November 8, 2017
Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer

At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …

News
promotional_banner

The End Game: Payer Engagement Webinar

November 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …

News
cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017
Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …

News
doctor_notes

Clinical trials still have a problem with ethnic minorities

November 8, 2017
Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical

Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …

News
novartis_outside_1

Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time

November 8, 2017
Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …

News
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,

News
mosquito

Breathalyser for malaria shows promise in trials

November 7, 2017
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …

News
roche_dark_0

FDA expands Roche drug indication to approve first-ever treatment for rare blood cancer

November 7, 2017
Manufacturing and Production, Sales and Marketing Cancer, Erdheim-Chester Disease, FDA, Roche, blood cancer, pharma

The FDA has announced the approval of Roche’s Zelboraf (vemurafenib) in the treatment of Erdheim-Chester Disease (ECD), expanding its already …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026